HCV NAT+/- in Abdominal Organ Transplantation: Where Are We Now and What's Next?

Wednesday, May 27, 2020 - 14:00 to 15:00

VIEW ARCHIVE

Speakers:
Norah Terrault, MD, MPH • Professor of Medicine, University of Southern California, Los Angeles, CA
Deirdre Sawinski, MD • Associate Professor of Medicine, University of Pennsylvania, Philadelphia, PA

Moderator:
Christine Durand, MD • Associate Professor of Medicine, Johns Hopkins University, Baltimore, MD

After participating in this webinar, the attendee will be able to:

  1. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for liver transplantation
  2. Understand the evolution of and current state of knowledge using HCV donors (NAT+/-) for kidney transplantation
  3. Describe future directions for utilization of HCV donors (NAT+/-) for abdominal organ transplantation
- - - - -

AST would like to thank the Infectious Disease (IDCOP), Kidney Pancreas (KPCOP), and Liver and Intestinal (LICOP) Communities of Practice for each recommending "HCV" as a topic for the 2019-2020 T3 series. The concept was expanded into two HCV NAT+/- sessions, one covering "HCV NAT+/- in Abdominal Organ Transplantation" and another covering "HCV NAT+/- in Thoracic Organ Transplantation." Learn more about AST's COPs at www.myast.org/cops.

Education Category: 
Series category: 
T3: Timely Topics in Transplantion